ALG1
Chitobiosyldiphosphodolichol beta-mannosyltransferase
Also known as: ALG1_HUMAN, CDG1K, HMAT1, HMT-1, Mat-1
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- Q9BT22
- Gene
- ALG1
- Ensembl
- ENSG00000033011
- Chromosome
- 16
- Canonical length
- 464 aa
- Protein class
- Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins
- Subcellular location
- Nucleoli fibrillar center,Endoplasmic reticulum
OverviewNCBI Gene
The enzyme encoded by this gene catalyzes the first mannosylation step in the biosynthesis of lipid-linked oligosaccharides. This gene is mutated in congenital disorder of glycosylation type Ik. [provided by RefSeq, Dec 2008]
Canonical amino-acid sequenceUniProt
464 residues, UniProt reviewed canonical sequence.
>Q9BT22|ALG1
1 MAASCLVLLA LCLLLPLLLL GGWKRWRRGR AARHVVAVVL GDVGRSPRMQ YHALSLAMHG
61 FSVTLLGFCN SKPHDELLQN NRIQIVGLTE LQSLAVGPRV FQYGVKVVLQ AMYLLWKLMW
121 REPGAYIFLQ NPPGLPSIAV CWFVGCLCGS KLVIDWHNYG YSIMGLVHGP NHPLVLLAKW
181 YEKFFGRLSH LNLCVTNAMR EDLADNWHIR AVTVYDKPAS FFKETPLDLQ HRLFMKLGSM
241 HSPFRARSEP EDPVTERSAF TERDAGSGLV TRLRERPALL VSSTSWTEDE DFSILLAALE
301 KFEQLTLDGH NLPSLVCVIT GKGPLREYYS RLIHQKHFQH IQVCTPWLEA EDYPLLLGSA
361 DLGVCLHTSS SGLDLPMKVV DMFGCCLPVC AVNFKCLHEL VKHEENGLVF EDSEELAAQL
421 QMLFSNFPDP AGKLNQFRKN LRESQQLRWD ESWVQTVLPL VMDTLocalizationUniProt · AlphaFold · HPA
Whether an antibody against ALG1 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 1
- Mean surface accessibility (rSASA)
- 0.24
- Highest tissue expression
- 23 nTPM
Expression across tissuesHPA
Tissue
- choroid plexus: 23 nTPM
- pancreas: 15 nTPM
- parathyroid gland: 15 nTPM
- colon: 15 nTPM
- rectum: 14 nTPM
- salivary gland: 14 nTPM
Single-cell type
- cone photoreceptor cells: 93 nCPM
- late spermatids: 36 nCPM
- late primary spermatocytes: 32 nCPM
- differentiating spermatogonia: 27 nCPM
- hofbauer cells: 26 nCPM
- early primary spermatocytes: 26 nCPM
Immune cell
- total PBMC: 94 nTPM
- myeloid DC: 64 nTPM
- gdT-cell: 62 nTPM
- memory CD8 T-cell: 62 nTPM
- non-classical monocyte: 61 nTPM
- T-reg: 60 nTPM
Brain region
- choroid plexus: 17 nTPM
- cerebral cortex: 12 nTPM
- hippocampal formation: 11 nTPM
- white matter: 11 nTPM
- basal ganglia: 11 nTPM
- pons: 11 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about ALG1.
Disease | AllUniProt
Conditions ALG1 is implicated in, by any mechanism.
- Congenital disorder of glycosylation 1K (CDG1K) MIM:608540
Disease | GeneticClinVar
119 pathogenic / likely-pathogenic of 1,000 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- ALG1-congenital disorder of glycosylation
- Congenital disorder of glycosylation
- Inborn genetic diseases
- ALG1-related disorder
- Finnish congenital nephrotic syndrome
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.5
- gnomAD pLI
- 0
- gnomAD missense Z
- -2.05
- DepMap mean gene effect
- -0.8
- DepMap dependency class
- common
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 6% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
Molecular functions
- mannosyltransferase activity
- chitobiosyldiphosphodolichol beta-mannosyltransferase activity
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads ALG1 as an antibody target. Whether an autoantibody or antibody against ALG1 could matter depends on whether native ALG1 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
ALG1 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label ALG1 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...